| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c945e6c777b22f25bd140bc81c7fa5b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2021-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_092da3ae15ca7ecdf59a5dde1c127e9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c4458c7b30ba18f2b3b7b92d1cc7ae3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cc7dc2fedc710c931d50d49a55ab2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea69e0cdfdbff4304707065f1644b858 |
| publicationDate |
2021-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2755233-C1 |
| titleOfInvention |
METHOD FOR TREATMENT OF SKIN MELANOMA OF STAGES IIb-IIc |
| abstract |
FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to oncology, and can be used in the treatment of skin melanoma of stages IIb-IIc. The method includes courses of chemotherapy with dacarbazine immediately after surgery, three times for 5 days by intravenous administration at doses of 250 mg/m 2 of the patient’s body area with an interval between courses of 3-4 weeks. After chemotherapy, interferon-α 3-5 million units immunotherapy is performed 3 times a week for a total duration of 12 months. n EFFECT: use of the invention makes it possible for patients with stage IIb- IIc skin melanoma to gain an advantage in progression-free survival, as well as in adjusted overall survival. n 1 cl, 2 tbl, 2 ex |
| priorityDate |
2021-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |